← Eichor
Condition: Alcohol Related Disorders Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alcohol Related Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
NA · 1 location(s) · University of Minnesota · NCT05062369
Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Phase N/A · 1 location(s) · National Institute on Drug Abuse (NIDA) · NCT06552741
Reducing Blood Pressure in Mid-life Adult Binge Drinkers
NA · 1 location(s) · The University of Texas at Arlington · NCT05522075
Evaluating a One-Year Version of the Parent-Child Assistance Program
NA · 2 location(s) · University of Oklahoma · NCT06163651
Social Cognition in Severe Alcohol Use Disorder
NA · 1 location(s) · CHU de Reims · NCT07464613
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603
Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191
Translation and Validation of the COMM and ASI-SR
Phase N/A · 1 location(s) · Uppsala University · NCT06084520
Effects of Ketogenic Diet on Alcohol Intoxication
NA · 1 location(s) · University of Pennsylvania · NCT07602270
LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
NA · 1 location(s) · University Hospital, Rouen · NCT03371641
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
Phase 2 · 1 location(s) · NYU Langone Health · NCT03667846
Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence
NA · 1 location(s) · Charite University, Berlin, Germany · NCT07388693
French National MICMAF Cohort
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05895890
Naltrexone in AUD Reward Drinkers
Phase 4 · 1 location(s) · University of Pennsylvania · NCT05028062
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229
Evaluation of the Implementation of a Parenting Program in Parents With Children Aged 4 to 12 Years and One Parent With
NA · 1 location(s) · University Hospital, Brest · NCT05490589
Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT06648642
Neural and Hormonal Influences on Sex Differences in Risk for AUD
NA · 1 location(s) · Jessica Weafer · NCT04929288
A Non-Inferiority Trial of an Electronic vs Face-to-face Brief Intervention After Alcohol Screening in Two Countries
NA · 2 location(s) · HBSA · NCT07150156
A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
Phase 1/Phase 2 · 4 location(s) · Clearmind Medicine Inc. · NCT05913752
CIFASD 5 tDCS and Cognitive Training
NA · 1 location(s) · University of Minnesota · NCT05456321
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150
Self-Concept and Autobiographical Memory in Alcohol Use Disorder
NA · 1 location(s) · CHU de Reims · NCT06985927
Evaluating Alcohol Use in Alcoholic Liver Disease
Phase N/A · 1 location(s) · Nicole T Shen · NCT03267069
Alcohol and Sexual Communication Among Couples in the Laboratory
NA · 1 location(s) · University of Colorado, Denver · NCT06865872
Human Laboratory Study of Apremilast for Alcohol Use Disorder
Phase 2 · 3 location(s) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT07325266
Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study
NA · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06835907
Examining the Relationship Between Physical Activity Levels and Chronotype Tendencies in Individuals With Alcohol Depend
Phase N/A · 1 location(s) · Gulhane School of Medicine · NCT06850428
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.